Multi-year program supports development of disposable molecular diagnostic platforms for point-of-care, field-use, and emergency response settings ... .
ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., July 15, 2026 (GLOBE NEWSWIRE) -- MolecularPartners AG (SIX ... Molecular Partners expects to announce a third Radio-DARPin program, targeting a different tumor target, in 2026.
Point-of-care molecular diagnostics market size is projected to reach USD 17.94 Bn by 2034 from its value of USD 8.46 billion in 2024, at a CAGR of 8.70% ... .
Multi-year program supports development of disposable molecular diagnostic platforms for point-of-care, field-use, and emergency response settings ... To ensure biosafety, the Sapphiros molecular device ...
At RDE of 32 mg QD, encouraging monotherapy responses with 57% uORR in 2L+ KRAS G12X pancreatic cancer in U.S. trial and median relative dose intensity of 100% ... .
Tuberculosis (TB), once considered a virtual “death sentence,” is now entering a new era of hope thanks to advances in molecular medicine and AI-driven healthcare technologies ... to molecular diagnosis.
It gives them the stability and tunable properties needed for applications ranging from targeted drug delivery and biosensing to designing precise molecular machines ... A broader route to molecular machines.
For researchers on the hunt for the genetic roots of disease, the cost of deep whole-genome sequencing makes it challenging to conduct large genetic studies involving thousands of participants, which are needed to reveal new genetic insights ...Toni A.
Until now, however, the molecular mechanisms driving pilin antigenic variation have remained elusive, according to Seifert ... Host-Pathogen InteractionsImmune EvasionEvolution, Molecular.